461 reports of this reaction
3.6% of all ICATIBANT ACETATE reports
#2 most reported adverse reaction
DRUG INEFFECTIVE is the #2 most commonly reported adverse reaction for ICATIBANT ACETATE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 461 FDA adverse event reports linking ICATIBANT ACETATE to DRUG INEFFECTIVE. This represents approximately 3.6% of all 12,796 adverse event reports for this drug.
Patients taking ICATIBANT ACETATE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among ICATIBANT ACETATE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for ICATIBANT ACETATE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 461 FDA reports for ICATIBANT ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.6% of all adverse event reports for ICATIBANT ACETATE, making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ICATIBANT ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.